Manasanch, Elisabet E. http://orcid.org/0000-0002-0857-176X
Kunacheewa, Chutima http://orcid.org/0000-0002-3429-5826
Claussen, Catherine M.
Lee, Hans C.
Thomas, Sheeba K.
Gunther, Jill
Pinnix, Chelsea C.
Dabaja, Bouthaina S.
Amini, Behrang http://orcid.org/0000-0002-4962-3466
Alexanian, Raymond
Orlowski, Robert Z. http://orcid.org/0000-0002-5723-4129
Dong, Wenli
Feng, Lei
Weber, Donna M.
Funding for this research was provided by:
Celgene
Amgen
Bristol-Myers Squibb
Janssen Biotech
Article History
Received: 30 June 2020
Revised: 17 August 2020
Accepted: 18 January 2021
First Online: 8 February 2021
Conflict of interest
: E.M. has received research support from Sanofi, Quest Diagnostics, Novartis, JW Pharma, Merck; consultant fees from Takeda, Celgene, Sanofi, Janssen and Adaptive Biotechnologies. C.K. reports no conflicts of interest. C.M.C. reports no conflicts of interest. H.L. has received consulting fees from Adaptive Biotechnologies, Celgene, Pimera, and Takeda, and research support from Amgen, Daiichi Sankyo, Janssen, and Takeda. S.T. reports no conflicts of interest. J.G. reports no conflicts of interest. C.C.P. reports no conflicts of interest. B.S.D. reports no conflicts of interest. B.A. reports no conflicts of interest. R.A. reports no conflicts of interest. R.O. has received consulting fees from Amgen, Bristol-Myers-Squibb, Celgene, GSK Biologicals, Ionis Pharmaceuticals, Janssen, Juno Therapeutics, Kite Pharma, Legend Biotech, Molecular Partners, Sanofi, Servier, and Takeda and research support from BioTheryX. W.D. reports no conflicts of interest. L.F. reports no conflicts of interest. D.W. reports no conflicts of interest.